🔎 Trials Near Me

Akèy › Maladi Parkinson › Kalifòni › San Francisco

Etid klinik pou Maladi Parkinson nan San Francisco, CA

14 etid pou Maladi Parkinson ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator

Ap rekrite
  • University of California San Francisco, San Francisco
Laj 25 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT07682311

Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease

Ap rekrite
  • University of California San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07398157

Parkinson's Foundation PD GENEration Genetic Registry

Ap rekriteEtid obsèvasyon
  • University of California San Francisco (UCSF), San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT04994015

Parkinson Progression Marker Initiative Online (PPMI Online)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • UCSF Movement Disorders and Neuromodulation Center (MDNC), San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05065060

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Ap rekriteEtid obsèvasyon
  • University of California, San Francisco, San Francisco
Tout laj · Tout sèks · Mizajou Sep 3, 2026 · NCT03664609

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Ap rekriteFaz 3
  • UCSF Weill Institute for Neurosciences, San Francisco
Laj 50 a 85 · Tout sèks · Mizajou Sep 3, 2026 · NCT07174310

Psilocybin Therapy for Depression in Parkinson's Disease

Ap rekriteFaz 2
  • University of California, San Francisco, San Francisco
Laj 40 a 80 · Tout sèks · Mizajou Aug 7, 2026 · NCT06455293

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of California, San Francisco, San Francisco
Laj 30 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT04477785

Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease

Ap rekrite
  • San Francisco Neurology and Sleep Center, San Francisco
Laj 50 a 90 · Tout sèks · Mizajou Jun 16, 2026 · NCT07554833

Understanding Motivation in Parkinson's Patients Through Neurophysiology

Ap rekrite
  • University of California San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Jun 5, 2026 · NCT05065151

Ketamine for Veterans With Parkinson's Disease

Ap rekriteFaz 2
  • San Francisco VA Medical Center, San Francisco, CA, San Francisco
Laj 40 a 80 · Tout sèks · Mizajou Apr 13, 2026 · NCT06231563

Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

Ap rekriteFaz 1 bonè
  • University of California, San Francisco
Laj 40 a 85 · Tout sèks · Mizajou Dec 23, 2025 · NCT06932809

Safety and Usability of the Cionic Neural Sleeve for Parkinson's Disease

Ap rekrite
  • CIONIC, San Francisco
Laj 22 a 75 · Tout sèks · Mizajou Dec 18, 2025 · NCT07284823

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

Ap rekriteFaz 1/2Volontè an sante akeyi
  • UCSF, San Francisco
Laj 18 a 80 · Tout sèks · Mizajou May 2, 2025 · NCT05395624

Etid Maladi Parkinson nan lòt vil

Lòt etid nan San Francisco

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.